NCT06124378 2025-09-24
Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer
First Affiliated Hospital of Guangxi Medical University
Phase 2 Active not recruiting
Clinical Trials
10 trialsNCT06646445 2025-06-13
PREMICES
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2 Not yet recruiting
NCT04231526 2024-07-31
Pembrolizumab in Early Stage Colon Cancer
University of Chicago
Phase 2 Withdrawn
NCT06017141 2023-08-30
Inhalational or Intravenous Anesthesia During Surgery for Patients With Colon Cancer, VIVA Study
University of Kansas Medical Center
Phase 2 Recruiting
NCT04712292 2022-02-28
COVID-CRC
University of Bologna
Unknown
NCT04851054 2021-04-20
Postoperative VEGF and Recurrence After Colon Cancer Surgery
Hospital del Mar
Unknown
NCT01363843 2020-06-11
Complete Neoadjuvant Treatment for REctal Cancer (CONTRE)
Brown University
Phase 2 Completed
NCT03826446 2019-02-01
Laparoscopic Versus Open Complete Mesocolic Excision With Central Vascular Ligation in Right Colon Cancer
Menoufia University
Phase NA Completed
NCT00310076 2018-08-23
Thalidomide in Treating Patients Who Have Undergone Surgery and Chemotherapy for Cancer That Has Spread Throughout the Abdomen Due to Colorectal Cancer or Appendix Cancer
Wake Forest University Health Sciences
Phase 2 Completed
NCT00003544 2013-06-26
Irinotecan in Treating Patients With Metastatic Colorectal Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed